tm logo
ABELZETA
Live/Pending
FIRST EXTENSION - GRANTED

granted

on 15 Jul 2024

Last Applicant/ Owned by

9605 MEDICAL CENTER DRIVE, SUITE 100

ROCKVILLE

MD

20850

Serial Number

98098345 filed on 24th Jul 2023

Registration Number

N/A

Correspondent Address

Lauren Beth Emerson

Lauren Beth Emerson LEASON ELLIS LLP

WHITE PLAINS, NY 10601

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

ABELZETA

Cell therapy services, namely, immune cell therapy services and medical treatment using cultured cells; Collection and preservation of biological tissue, blood and cells; providing medical information; providing health information in the field of oncology; providing medical information in the field of pharmaceuticals and cell therapy; medical treatment services, namely, medical treatment of cancer Read More

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Cell therapy services, namely, immune cell therapy services and medical treatment using cultured cells; Collection and preservation of biological tissue, blood and cells; providing medical information; providing health information in the field of oncology; providing medical information in the field of pharmaceuticals and cell therapy; medical treatment services, namely, medical treatment of cancer, autoimmune, and inflammatory diseases; medical diagnostic services


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [041]
Education and Entertainment Services


Educational services, namely, the presentation of lectures and panel discussions in the field of medicine


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [040]
Treatment & Processing of Materials Services


Custom manufacturing of biological tissue, blood, and cells; custom manufacturing of pharmaceutical preparations for immunotherapy; custom manufacture of pharmaceutical and biological preparations for medical use, namely, for the prevention and treatment of cancer and autoimmune diseases; custom manufacture of viral vectors and plasmids for research and clinical use; custom manufacture of excipients for use in the manufacture of pharmaceutical and biological preparations for research and medical use


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Pharmaceutical and biological preparations for medical use, namely, for the treatment and prevention of diseases, namely, cancer and autoimmune diseases; pharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment of cancer; pharmaceutical and biological preparations for immunotherapy; pharmaceutical and biological preparations for medical diagnostic use; diagnostic kits consisting primarily of cells for medical or clinical use; viral vectors and plasmids for clinical use; cells for medical use


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [001]
Chemical Products


Excipients for use in the manufacture of pharmaceutical and biological preparations for research and medical use; viral vectors and plasmids for scientific research


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98098345

Mark Type

No Service Mark

Attorney Docket Number

No 11299/316769

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

27.03.05 -

Representations of objects forming letters or numerals, including punctuation

28.01.05 -

Inscriptions in Greek and Cyrillic characters Formerly Inscriptions in Greek characters

Legal History


Show more

Status DateAction Taken
15th Jul 2024SOU EXTENSION 1 FILED
15th Jul 2024SOU EXTENSION 1 GRANTED
15th Jul 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
15th Jul 2024SOU TEAS EXTENSION RECEIVED
02th Jul 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07th May 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07th May 2024PUBLISHED FOR OPPOSITION
17th Apr 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
29th Mar 2024APPROVED FOR PUB - PRINCIPAL REGISTER
29th Mar 2024EXAMINER'S AMENDMENT ENTERED